right now the issue is financing because our rev

right now the issue is financing because our revenue opportunities slipped into 2022. i wish they addressed this in the CC but the vibe I got from management was they are shifting hard to the post covid treatment , being LH, and have little left to hang our hat on other than Brazil for the treatment for seriously ill Covid patients. Canada and Philippines were skipped over pretty quickly during the Q and A ..

My concern now is I'm not sure how we pull off a large Long Hauler phase 3 without a partner willing to foot the bill for the trial and perhaps pay us for the licensing of the drug for LH should i make it thru the process .I really dont want to see continued rounds of borrowing thru "The Bank of Fife"...I do believe with DR Recknor at the helm the BLA for HIV will hit its dates but that is still a 2022 revenue event